# Phase 4 Professor Committee Simulation, Cycle 3

Scope: active English build inputs only (`front_en/abstract.tex`, `chapters_en/ch1_introduction.tex`, `chapters_en/ch3_methods.tex`, `chapters_en/ch4_results.tex`, `chapters_en/ch5_discussion.tex`). Orphan files were not used as evidence. Phase 3 CCB is consumed as supplied: **0 unresolved Critical findings, Phase 4 entry PASS**. This score reflects the updated Cycle 3 manuscript state after the four surgical B/D/E/G edits.

## Gate Verdict

**PASS for this audit cycle.**

- Total score: **82.0 / 100**
- Lowest item mean: **7.8** (H. 서술 명확성)
- Phase 3 unresolved Critical findings: **0**
- Gate result: total >= 80, no item mean < 6, and no unresolved Critical findings.

The Cycle 3 edits lift the Cycle 2 deductions on related work, experimental scale, result interpretation, and practical value. The manuscript now separates true model-family comparison from Tranception-proxy/ESM-2 channel comparison (`chapters_en/ch5_discussion.tex:169`), states what would change at 20--30 pathogens in inferential rather than raw-scale terms (`chapters_en/ch5_discussion.tex:179`), replaces causal biological shorthand with "pathogen-specific benchmark behavior" and explicitly avoids isolating one causal component (`chapters_en/ch4_results.tex:895`), and adds a near-term use boundary that restricts MutBench to retrospective prioritization until callability and adaptive-method criteria are met (`chapters_en/ch5_discussion.tex:281`-`282`).

## Committee Matrix

Columns A-J: A problem definition, B related work, C methodology, D experimental scale, E result interpretation, F originality, G practical value, H clarity, I limitations, J completion.

| Professor | A | B | C | D | E | F | G | H | I | J | Mean |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| 1. Chair, bioinformatics | 9 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 8.4 |
| 2. Advisor, computer science | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 8 | 8.2 |
| 3. Statistics/ML | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 8 | 8.1 |
| 4. Computational biology | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 8 | 8.2 |
| 5. Virology/public health | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 8 | 8.2 |
| 6. VEP/PLM expert | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 9 | 8 | 8.0 |
| 7. Benchmark methodology | 9 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 8.4 |
| 8. Practice/field user | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 9 | 8 | 8.1 |
| 9. Statistical genetics | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 9 | 8 | 8.2 |
| 10. Structural biology | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 8 | 8.2 |

## Item Means

| Item | Mean |
|---|---:|
| A. 문제 정의 | 8.7 |
| B. 관련 연구 | 8.0 |
| C. 방법론 | 8.3 |
| D. 실험 규모 | 8.0 |
| E. 결과 해석 | 8.0 |
| F. 기여 독창성 | 8.0 |
| G. 실용 가치 | 8.0 |
| H. 서술 명확성 | 7.8 |
| I. 한계 인식 | 9.0 |
| J. 완성도 | 8.2 |

Total score is the sum of item means: **82.0 / 100**.

## Cycle 3 Lifted Deductions

**B. Related work, mean lifted from 7.9 to 8.0.** The prior PLM/VEP ambiguity is now sufficiently bounded: the text says the benchmark distinguishes true model-family comparison from the Tranception-proxy versus ESM-2 LLR proxy-channel comparison, and positions MutBench as region-level detection rather than per-variant fitness regression (`chapters_en/ch5_discussion.tex:169`). A residual deduction remains because the headline still requires readers to track channel collinearity across the abstract and discussion (`front_en/abstract.tex:13`), but this is now a concrete limitation rather than an unresolved positioning problem.

**D. Experimental scale, mean lifted from 7.9 to 8.0.** The manuscript already had broad evaluation coverage: 8,580 cells in the main 11-pathogen panel (`front_en/abstract.tex:2`, `chapters_en/ch1_introduction.tex:146`). The new note clarifies that expansion to 20--30 pathogens would improve random-effects inference, ICC precision, callability reachability, and LOPO-vs-oracle partitioning rather than simply increasing the count of evaluations (`chapters_en/ch5_discussion.tex:179`). The remaining deduction is the unavoidable 11-cluster limit for cross-pathogen generalization.

**E. Result interpretation, mean lifted from 7.8 to 8.0.** The updated Chapter 4 language avoids over-attributing the interaction to biology by naming pathogen-specific benchmark behavior as a mixture of biology, curation protocol, auxiliary input quality, and their interaction, with no single component isolated as causal (`chapters_en/ch4_results.tex:895`). This aligns with the abstract's caveat that Layer A partly confounds biology with curation protocol (`front_en/abstract.tex:2`) and Chapter 5's scoring-input heterogeneity discussion (`chapters_en/ch5_discussion.tex:188`).

**G. Practical value, mean lifted from 7.7 to 8.0.** The new recommended-use paragraph now states the operational boundary directly: retrospective prioritization only, abstention status reported, and no prospective detector or callability claim until expanded-panel quorum and adaptive methods beat EqualWeight under paired nested-LOPO (`chapters_en/ch5_discussion.tex:281`-`282`). This harmonizes with the abstract's HIV-1 search-space-reduction anchor and negative/abstention constraints (`front_en/abstract.tex:11`) and with the algorithm framing as a retrospective cold-start heuristic (`chapters_en/ch4_results.tex:696`).

## Means Below 8

**H. 서술 명확성, mean 7.8.** Strongest reason: the dissertation is technically candid but dense. Several major caveat clusters are packed into long paragraphs, especially the audit-boundary material (`chapters_en/ch5_discussion.tex:270`-`278`) and the extended future-work/callability discussion (`chapters_en/ch5_discussion.tex:308`-`310`). Smallest targeted fix: convert the main "claim / evidence / boundary / allowed use" content into one compact summary table near the end of Chapter 5, while leaving the detailed prose as support.

## No Scores Below 6

No professor assigned any item score below 6, so no sub-6 one-sentence rationales are required.

## Diagnostic Criterion

Skill-defined diagnostic criterion, reported but not used as the gate:

- Mean >= 7: **PASS** (overall mean 8.20)
- Individual minimum >= 5: **PASS** (minimum individual score 7)

## Overall Assessment

The updated dissertation is committee-passable and more defensible than Cycle 2. The strongest areas are problem definition, limitation awareness, methodological detail, and completion of the benchmark-plus-audit package. The remaining weaknesses are no longer gate-level: the central inference is still limited by 11 pathogen clusters, practical deployment remains retrospective rather than prospective, and the prose is dense enough that committee readers may need summary scaffolding. The Cycle 3 edits correctly convert prior low-8 concerns into bounded scope limitations rather than unresolved conceptual problems.
